FLUCLOXACILLIN BAXTER (Baxter Healthcare Pty Ltd)
Product name
FLUCLOXACILLIN BAXTER
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 (255 working days)
Active ingredients
flucloxacillin sodium monohydrate
Registration type
New generic medicine
Indication
For the treatment of confirmed or suspected Staphylococcal and other Gram-positive coccal infections. Indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.